featured
CDK4/6 Inhibitors for HR+ Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cyclin-Dependent Kinase 4 and 6 Inhibitors for Hormone Receptor-Positive Breast Cancer: Past, Present, and Future
Lancet 2020 Mar 07;395(10226)817-827, LM Spring, SA Wander, F Andre, B Moy, NC Turner, A BardiaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.